Claritin /00413701/


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 61.5%
Chest Pain 7.7%
Chronic Obstructive Pulmonary Disease 7.7%
Cough 7.7%
Dyspnoea 7.7%
Sinusitis 7.7%
Urticaria 100.0%
Concomitant
Product Used For Unknown Indication 53.9%
Hypersensitivity 6.0%
Hepatitis C 5.2%
Rheumatoid Arthritis 3.6%
Dysmenorrhoea 3.2%
Hypertension 2.8%
Type 2 Diabetes Mellitus 2.8%
Type 1 Diabetes Mellitus 2.7%
Hypothyroidism 2.5%
Sinusitis 2.4%
Psoriasis 2.2%
Psoriatic Arthropathy 2.2%
Osteoporosis Postmenopausal 2.1%
Attention Deficit/hyperactivity Disorder 1.6%
Seasonal Allergy 1.4%
Anaemia 1.3%
Asthma 1.3%
Chronic Hepatitis C 0.9%
Idiopathic Thrombocytopenic Purpura 0.9%
Sinus Disorder 0.9%
Sinusitis 15.3%
Therapeutic Response Decreased 10.6%
Product Quality Issue 7.1%
Wrong Technique In Drug Usage Process 5.9%
Drug Ineffective 4.7%
Injection Site Reaction 4.7%
Injection Site Swelling 4.7%
Pancreatitis Acute 4.7%
Psoriasis 4.7%
Completed Suicide 3.5%
Injection Site Urticaria 3.5%
Injection Site Warmth 3.5%
Nausea 3.5%
Rash 3.5%
Rash Papular 3.5%
Upper Respiratory Tract Infection 3.5%
Urticaria 3.5%
Viral Infection 3.5%
Vomiting 3.5%
Convulsion 2.4%

Drug Data